Skip to main content
Premium Trial:

Request an Annual Quote

Luxembourg Center Taps Biobase to Analyze NGS Variants for Clinical Diagnostics

Premium

Biobase said this week that the Luxembourg Center for Systems Biomedicine will use its Genome Trax software to analyze next-generation sequencing data for use in clinical diagnostics.

Additionally, Biobase said that it will work with LCSB to establish “a hub of expertise” for the application of the company’s products and to provide data analysis, training, and support to researchers in Luxembourg and surrounding countries.

In a statement, Reinhard Schneider, who heads the bioinformatics core facility at LCSB, said that the mutation, regulation, and pharmacogenomics data in Genome Trax are “crucial for the annotation of our clinical data.”

He described LCSB’s collaboration with Biobase “as a strategic partnership to advance the clinical application of NGS technology."

Genome Trax helps users prioritize human genome variants in whole-genome or exome data. The tool maps NGS data to known features such as disease mutations and regulatory sites, allowing users identify novel mutations that could affect the function of candidate disease genes.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.